• Dr Darrin Disley
  • Healthcare Transforming Technology  takes Business Award
    Prof Julian Gough
  • Dr Darrin Disley
  • Healthcare Transforming Technology  takes Business Award
    Prof Julian Gough

News

Healthcare Transforming Technology  takes Business Award

Cell therapies developer Mogrify has won the AstraZeneca Life Science Innovation category of the Business Weekly Awards announced in September, for its proprietary direct cellular conversion technology to further the cause of life science discovery. Co-founder and CSO Prof. Julian Gough, also received the Cambridge Enterprise Academic Entrepreneur of the Year award in recognition of his work as a life science innovator.

The company’s platform technology determines the conversion factors required to convert (ex vivo or in vivo) any target cell type from any source cell type and is being deployed to engineer an evergreen and scalable source of cell types that exhibit efficacy and safety profiles necessary to addess diseases with a high unmet clinical need, such as in ophthalmological, immunological, hematological and other disease areas.

Prof. Gough is a leading bioinformatician and biotech entrepreneur who led the development and application of this platform which utilises a systematic big-data approach (Rackham et al., Nature Genetics, 2016) developed over a 10-year period via a multi-national research collaboration. Graduating with a PhD in molecular biology from the University of Cambridge, Julian became Professor of Bioinformatics at the University of Bristol and is now Programme Leader at the MRC Laboratory of Molecular Biology in Cambridge. He has also successfully started a number of biotech companies.

Dr. Darrin M. Disley, OBE, CEO, Mogrify, said: “Our team are committed to transforming healthcare for indications of high unmet clinical need. The award for Life Science Innovation attests to the potential of Mogrify’s platform and pioneering team to overcome safety, efficacy and scalability challenges for cell therapies and we are honoured to have this recognised by the judges at this year’s esteemed business awards.

“Julian is an outstanding scientist and entrepreneur who has worked tirelessly to advance Mogrify technology and drive its therapeutic application forward, paving the way for future treatments and inspiring those who work alongside him.”

Since February 2019, Mogrify has raised over $20 million USD in seed and series A rounds and $2.5 million USD in grant funding, and has grown to a headcount over 60 of scientific, operational and commercial staff.


Digital Edition

ILM 50.2 March 2025

March 2025

Chromatography Articles - Effects of small deviations in flow rate on GPC/SEC results Mass Spectrometry & Spectroscopy Articles - Waiting for the present to catch up to the future: A bette...

View all digital editions

Events

Bio-Europe Spring

Mar 17 2025 Milan, Italy

NGVS 2025

Mar 18 2025 Beijing, China

Laborama 2025

Mar 20 2025 Brussels, Belgium

Asia Labex

Mar 20 2025 Chandigarh, India

ACS National Meeting & Expo, Spring 2025

Mar 23 2025 San Diego, CA, USA

View all events

Redirecting you now.
Labmate Awards Nominations - Open
The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.